A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie's disease

被引:41
|
作者
Patel, Darshan P. [1 ]
Christensen, Michael B. [1 ]
Hotaling, James M. [1 ]
Pastuszak, Alexander W. [1 ]
机构
[1] Univ Utah, Div Urol, Dept Surg, Ctr Reconstruct Urol & Mens Hlth,Sch Med, 30 N 1900 E,Rm 3B420, Salt Lake City, UT 84132 USA
关键词
Peyronie's disease; Penile induration; Dupuytren's contracture; Ledderhose disease; Fibrosis; Inflammation; Transforming growth factor beta; Cytokines; GROWTH-FACTOR-BETA; TGF-BETA; GENE-EXPRESSION; MATRIX METALLOPROTEINASES; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; DUPUYTRENS-DISEASE; ASSOCIATION; TISSUE; PATHOPHYSIOLOGY;
D O I
10.1007/s00345-019-02815-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Peyronie's disease (PD) is a superficial fibrosing disorder that causes penile deformity and can interfere with sexual intercourse and reproduction, as well as diminish quality of life. While the exact mechanism of PD is still being investigated, there is likely a genetic component to the predisposition to penile plaque formation. Ultimately, however, perturbations in normal wound healing and aberrant deposition of extracellular matrix components lead to fibrotic tissue deposition. Fibrosis in PD is regulated by a complex pathway of inflammatory and fibrotic mediators. Currently there are no treatments for PD that address an underlying cause or disease progression. In this review, we provide an overview of the known inflammatory and fibrotic mediators of PD and explore the pathophysiology of other human superficial fibrosing disorders to develop further insights into PD.
引用
收藏
页码:253 / 261
页数:9
相关论文
共 50 条
  • [21] Peyronie's Disease: Evaluation and Review of Nonsurgical Therapy
    Abern, Michael R.
    Levine, Laurence A.
    THESCIENTIFICWORLDJOURNAL, 2009, 9 : 665 - 675
  • [22] Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction
    Campbell, Jeffrey
    Alzubaidi, Raidh
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (01) : 46 - 59
  • [23] The association between Peyronie's and Dupuytren's disease
    H M Nugteren
    J M Nijman
    I J de Jong
    M F van Driel
    International Journal of Impotence Research, 2011, 23 : 142 - 145
  • [24] The association between Peyronie's and Dupuytren's disease
    Nugteren, H. M.
    Nijman, J. M.
    de Jong, I. J.
    van Driel, M. F.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2011, 23 (04) : 142 - 145
  • [25] Significant Alterations of Serum Cytokine Levels in Patients with Peyronie's Disease
    Zimmermann, Reinhold P.
    Feil, Gerhard
    Bock, Conny
    Hoeltl, Lorenz
    Stenzl, Arnulf
    INTERNATIONAL BRAZ J UROL, 2008, 34 (04): : 457 - 466
  • [26] Medicolegal implications of Peyronie's disease: imprisonment or acquittal
    Mohanty, Kailash C.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (07) : 488 - 490
  • [27] Peyronie's disease: perspectives on therapeutic targets
    Abdel-Hamid, Ibrahim A.
    Anis, Tarek
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (08) : 913 - 929
  • [28] Extracellular matrix alterations in the Peyronie's disease
    Watanabe, Marcelo Silva
    Theodoro, Therese Rachel
    Coelho, Natalia Lima
    Mendes, Aline
    Pereira Leonel, Monica Luzia
    Mader, Ana Maria
    Nader, Helena Bonciani
    Glina, Sidney
    Silva Pinhal, Maria Aparecida
    JOURNAL OF ADVANCED RESEARCH, 2017, 8 (04) : 455 - 461
  • [29] Psychological Impact of Peyronie's Disease: A Review
    Nelson, Christian J.
    Mulhall, John P.
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 (03): : 653 - 660
  • [30] Peyronie's disease: Review and recent advances
    Langston, Joshua P.
    Carson, Culley C., III
    MATURITAS, 2014, 78 (04) : 341 - 343